Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statements of Changes in Shareholders' Equity

v3.23.1
Interim Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Contributed Surplus [Member]
Share Capital [Member]
Accumulated other comprehensive Income [Member]
Accumulated Deficit [Member]
Balance, shares at Dec. 31, 2021     216,782,694    
Balance, amount at Dec. 31, 2021 $ 69,386 $ 20,040 $ 248,319 $ 4,142 $ (203,115)
Exercise of stock options, shares     239,422    
Exercise of stock options, amount 171 (73) $ 244 0 0
Exercise of warrants, shares     259,000    
Exercise of warrants, amount 308 0 $ 308 0 0
Shares issued for cash, shares     1,214,774    
Shares issued for cash, amount 2,128 0 $ 2,128 0 0
Less share issue costs (53) 0 (53) 0 0
Stock compensation 261 261 0 0 0
Comprehensive loss (7,036) 0 0 (108) (6,928)
Balance, amount at Mar. 31, 2022 65,165 20,228 $ 250,946 4,034 (210,043)
Balance, shares at Mar. 31, 2022     218,495,890    
Balance, shares at Dec. 31, 2022     224,699,621    
Balance, amount at Dec. 31, 2022 62,499 19,843 $ 258,646 4,265 (220,255)
Exercise of stock options, shares     536,183    
Exercise of stock options, amount 298 (131) $ 429 0 0
Shares issued for cash, shares     39,491,000    
Shares issued for cash, amount 37,528 0 $ 37,528 0 0
Less share issue costs (2,992) 0 (2,992) 0 0
Stock compensation 253 253 0 0 0
Comprehensive loss (1,030) 0 0 (317) (713)
Balance, amount at Mar. 31, 2023 $ 96,556 $ 19,965 $ 293,611 $ 3,948 $ (220,968)
Balance, shares at Mar. 31, 2023     264,726,804